Colinz Laboratories Ltd

NSE: COLINZ · BSE: 531210 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹71.80
Market cap: ₹18.09 Cr
Revenue (annual): ₹6.14 Cr
Net profit (annual): ₹0.51 Cr
P/E (TTM): 6.5×Sector 47.4×
Promoter holding: 50.60%-15.40% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

21 Apr 2026 15:25 IST BSE

Colinz Laboratories Board Meeting Outcome

Colinz Laboratories Ltd has scheduled a Board Meeting on April 29, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. Consequently, the trading window for dealing in company securities remains closed from April 1, 2026, until 48 hours after the results declaration.

Read the filing ↗